CompletedNot Applicable

Rosacea Treatment Using Non-thermal (Cold) Atmospheric Plasma Device

United States5 participantsStarted 2024-01-02

Plain-language summary

10-13 patients will be enrolled to receive split face treatment: the control side will be treated with metronidazole cream, the intervention side will be treated with a cold atmospheric plasma device

Who can participate

Age range

18 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Papulopustular rosacea of the cheeks * Ability to complete six weeks of twice-weekly treatments Exclusion Criteria: * substantial asymmetry of disease distribution * previous failure of topical ivermectin treatment * presence of any other facial dermatoses * presence of any photosensitizing disorders * systemic tetracycline, systemic or topical ivermectin treatment within 6 weeks of start date * current or within prior 3 months treatment with systemic immune-suppressive medication

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

Efficacy - Investigator global assessment

Timeframe: 6 weeks

RosaQoL change

Timeframe: 6 weeks

Demodex count change

Timeframe: 6 weeks

Efficacy - National Rosace Society Expert Committee grading system

Timeframe: 6 weeks

Trial details

NCT IDNCT05592548

SponsorThe Skin Center Dermatology Group

Sponsor typeINDUSTRY

Study typeINTERVENTIONAL

Primary completion2024-05-31

View on ClinicalTrials.gov More Rosacea, Papulopustular trials

Who can participate

Age range

18 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.